New York State Common Retirement Fund Vaxcyte, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Vaxcyte, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 121,787 shares of PCVX stock, worth $5.89 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
121,787
Previous 125,087
2.64%
Holding current value
$5.89 Million
Previous $4.07 Million
7.87%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding PCVX
# of Institutions
322Shares Held
134MCall Options Held
408KPut Options Held
116K-
Janus Henderson Group PLC London, X013.1MShares$633 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$596 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA12MShares$578 Million7.4% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$480 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.32MShares$402 Million0.18% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.87B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...